Price T Rowe Associates Inc Adaptive Biotechnologies Corp Transaction History

Price T Rowe Associates Inc

  • $869 Billion
  • Q3 2024

A detailed history of Price T Rowe Associates Inc transactions in Adaptive Biotechnologies Corp stock. As of the latest transaction made, Price T Rowe Associates Inc holds 159,823 shares of ADPT stock, worth $891,812. This represents 0.0% of its overall portfolio holdings.

Number of Shares
159,823
Previous 158,807 0.64%
Holding current value
$891,812
Previous $575,000 42.43%
% of portfolio
0.0%
Previous 0.0%

Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024
BUY
$3.37 - $5.12 $3,423 - $5,201
1,016 Added 0.64%
159,823 $819,000
Q2 2024

Aug 14, 2024
BUY
$2.34 - $3.96 $8,372 - $14,168
3,578 Added 2.3%
158,807 $575,000
Q1 2024

May 15, 2024
SELL
$2.88 - $4.8 $396,446 - $660,744
-137,655 Reduced 47.0%
155,229 $499,000
Q4 2023

Feb 14, 2024
SELL
$3.46 - $5.33 $54,899 - $84,571
-15,867 Reduced 5.14%
292,884 $1.44 Million
Q3 2023

Nov 14, 2023
SELL
$5.07 - $8.44 $6.28 Million - $10.5 Million
-1,238,541 Reduced 80.05%
308,751 $1.68 Million
Q2 2023

Aug 14, 2023
SELL
$6.19 - $8.78 $1.31 Million - $1.86 Million
-211,657 Reduced 12.03%
1,547,292 $10.4 Million
Q1 2023

May 15, 2023
SELL
$7.8 - $10.11 $620,232 - $803,916
-79,517 Reduced 4.33%
1,758,949 $15.5 Million
Q4 2022

Feb 14, 2023
SELL
$6.26 - $9.34 $335,648 - $500,792
-53,618 Reduced 2.83%
1,838,466 $14 Million
Q3 2022

Nov 14, 2022
SELL
$6.5 - $12.67 $66.9 Million - $130 Million
-10,291,811 Reduced 84.47%
1,892,084 $13.5 Million
Q2 2022

Aug 15, 2022
SELL
$6.4 - $14.73 $1.49 Million - $3.42 Million
-232,472 Reduced 1.87%
12,183,895 $98.6 Million
Q1 2022

May 16, 2022
SELL
$10.12 - $28.9 $8.81 Million - $25.2 Million
-870,346 Reduced 6.55%
12,416,367 $172 Million
Q4 2021

Feb 14, 2022
BUY
$25.17 - $36.85 $46.3 Million - $67.8 Million
1,840,491 Added 16.08%
13,286,713 $373 Million
Q3 2021

Nov 15, 2021
BUY
$30.02 - $39.87 $14.4 Million - $19.1 Million
479,331 Added 4.37%
11,446,222 $389 Million
Q2 2021

Aug 16, 2021
BUY
$32.22 - $44.59 $43.3 Million - $59.9 Million
1,342,666 Added 13.95%
10,966,891 $448 Million
Q1 2021

May 17, 2021
BUY
$37.26 - $67.74 $137 Million - $249 Million
3,669,449 Added 61.62%
9,624,225 $387 Million
Q4 2020

Feb 16, 2021
BUY
$45.01 - $65.47 $268 Million - $390 Million
5,954,776 New
5,954,776 $352 Million

Others Institutions Holding ADPT

# of Institutions
202
Shares Held
146M
Call Options Held
68.8K
Put Options Held
42.5K
View Full List

About Adaptive Biotechnologies Corp

ADPT Quotes by TradingView
  • Ticker ADPT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 142,872,992
  • Market Cap $797M
  • Description
  • Adaptive Biotechnologies Corporation, a commercial-stage company, develops an immune medicine platform for the diagnosis and treatment of various diseases. The company offers immunoSEQ, a platform and core immunosequencing product that is used to answer translational research questions, as well as to discover new prognostic and diagnostic signal...
More about ADPT
Track This Portfolio

Track Price T Rowe Associates Inc Portfolio

Follow Price T Rowe Associates Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Price T Rowe Associates Inc , based on Form 13F filings with the SEC.

News

Stay updated on Price T Rowe Associates Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email